South & Central America Veterinary Vaccines Market Analysis and Forecast by Size, Share, Growth, Trends 2031
South & Central America Veterinary Vaccines Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Other Technologies), Animal Type [Companion (Dogs, Cat, Horses, and Other Companions) and Livestock and Poultry (Chicken, Cattle, and Other Poultry)], Route of Administration (Intramuscular, Subcutaneous, and Other Route of Administrations), and End Users (Veterinary Hospitals, Veterinary Clinics, and Other End Users)
- Status : Published
- Report Code : TIPRE00041793
- Category : Life Sciences
- No. of Pages : 181
- Available Report Formats :
The South & Central America Veterinary Vaccines Market size is expected to reach US$ 357.1 Million by 2031 from US$ 294.0 Million in 2024. The market is estimated to record a CAGR of 2.8% from 2025 to 2031.
Executive Summary and South & Central America Veterinary Vaccines Market Analysis:The veterinary vaccines market in South & Central America, comprising Brazil, Argentina, and other regions, accounts for a significant portion of the global market and is expected to grow robustly in the near future. The major driver of this growth is the increasing demand for animal by-products (ex., meat, milk, and eggs), which creates demand for preventing disease in livestock. Ongoing innovation by manufacturers in vaccinations (to improve effectiveness, safety, and delivery) will also support growth. Government initiatives to enhance animal health, advance vaccine research, and enhance veterinary services and healthcare are also supportive of growth. Brazil and Argentina are significant livestock producers and are also witnessing advances in the pet care and pet products markets, both of which are expected to drive growth in vaccination and animal health. Other areas of South & Central America are increasing focus on modern veterinary healthcare, particularly in traditional livestock production.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
South & Central America Veterinary Vaccines Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- By Technology, the South & Central America Veterinary Vaccines Market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others. Live Attenuated Vaccines held the largest share of the market in 2024.
- By Animal Type, the South & Central America Veterinary Vaccines Market is segmented into Companion and Livestock and Poultry. Livestock and Poultry held the largest share of the market in 2024.
- By Companion, the South & Central America Veterinary Vaccines Market is segmented into Dogs, Cat, Horses, and Others. Dogs held the largest share of the market in 2024.
- By Livestock and Poultry, the South & Central America Veterinary Vaccines Market is segmented into Chicken, Cattle, and Others. Chicken held the largest share of the market in 2024.
- By Route of Administration, the South & Central America Veterinary Vaccines Market is segmented into Intramuscular, Subcutaneous, and Others. Intramuscular held the largest share of the market in 2024.
- By End User, the South & Central America Veterinary Vaccines Market is segmented into Veterinary Hospitals, Veterinary Clinics, and Others. Veterinary Hospitals held the largest share of the market in 2024.
The increase in manufacturing plants is a significant growth prospect for the veterinary vaccines market. It solves pressing issues, including production scalability, reducing costs, and making vaccines more accessible regionally. With the soaring demand for veterinary vaccines fueled by increasing pet ownership, livestock husbandry requirements, and international disease prevention programs, producers are spending on new plants and renovating old ones to boost production capacity. In 2025, CDV Laboratorio announced the expansion of its operations in Pilar Industrial Park, Buenos Aires province, with a 26% growth projection for 2025 as part of its strategy to become one of the top 20 global veterinary vaccine labs. The expansion includes the construction of a third plant and a significant investment in new facilities. Also, in 2024, Biogénesis Bagó (Argentina/Brazil) opened a new vaccine-production plant in Campo Largo, Brazil, with an investment of around US$ 30 million. The facility will have an annual capacity of over 10 million doses and serve both pet and farm animal vaccines.
These expansions add supply to address worldwide demand and reduce the cost of production through economies of scale. Regional manufacturing facilities ensure quicker distribution and lower import reliance, especially in developing countries such as India, Brazil, and Africa. Governments and institutions promote local manufacturing through incentives, which has promoted local production of veterinary products. These investments provide opportunities for efficiency, innovation, and increased vaccine availability.
South & Central America Veterinary Vaccines Market Country InsightsBy country, the South & Central America Veterinary Vaccines Market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2024.
According to the PAHO, between EW 1 and EW 52 of 2024, 15 outbreaks of avian influenza A(H5) have been confirmed in wild birds in the Brazilian states of Espírito Santo, Rio de Janeiro, Rio Grande do Sul, and São Paulo. The rise in zoonotic diseases like avian influenza and the increasing risk of foot-and-mouth disease (FMD) are driving government initiatives to enhance vaccination campaigns across the country. Brazil's Ministry of Agriculture and Livestock (MAPA) has implemented programs to control and eradicate FMD. Such initiatives by the Government of Brazil are creating opportunities for market players to expand their presence in the country. In July 2024, Biogénesis Bagó, the leading global biotech company in the animal health, productivity, and welfare sector, opened a vaccine production plant in Campo Largo, Brazil, requiring a US$ 30 million investment. Beginning in 2026, the new facility will produce more than 10 million doses of live attenuated virus vaccines each year, initially concentrating on feline trivalent vaccines and canine quintuple/sextuple vaccines, both with and without leptospira.
South & Central America Veterinary Vaccines Market Company ProfilesSome of the key players operating in the market include Merck & Co Inc, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc, Elanco Animal Health Inc, Virbac SA, Neogen Corp, Hester Biosciences Ltd, HIPRA SA, and Biovac LTD.
These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
South & Central America Veterinary Vaccines Market Research MethodologyThe following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites,
annual reports, financial statements, broker analyses, and investor presentationsIndustry trade journals
and other relevant publicationsGovernment documents,
statistical databases, and market reportsNews articles,
press releases, and webcasts specific to companies operating in the market
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.Primary Research
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders:
Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales ManagersExternal experts:
Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Veterinary Vaccines Market Landscape
4.2 PEST Analysis
5. South & Central America Veterinary Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Veterinary Vaccines Market - South & Central America Market Analysis
6.1 South & Central America Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Veterinary Vaccines Market Forecast and Analysis
7. South & Central America Veterinary Vaccines Market Revenue Analysis - by Technology
7.1 Live Attenuated Vaccines
7.1.1 Overview
7.1.2 Live Attenuated Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated Vaccines
7.2.1 Overview
7.2.2 Inactivated Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Recombinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Toxoid Vaccines
7.4.1 Overview
7.4.2 Toxoid Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. South & Central America Veterinary Vaccines Market Revenue Analysis - by Animal Type
8.1 Companion
8.1.1 Overview
8.1.2 Companion: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Livestock and Poultry
8.2.1 Overview
8.2.2 Livestock and Poultry: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. South & Central America Veterinary Vaccines Market Revenue Analysis - by Companion
9.1 Dogs
9.1.1 Overview
9.1.2 Dogs: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Cat
9.2.1 Overview
9.2.2 Cat: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Horses
9.3.1 Overview
9.3.2 Horses: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. South & Central America Veterinary Vaccines Market Revenue Analysis - by Livestock And Poultry
10.1 Chicken
10.1.1 Overview
10.1.2 Chicken: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Cattle
10.2.1 Overview
10.2.2 Cattle: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. South & Central America Veterinary Vaccines Market Revenue Analysis - by Route Of Administration
11.1 Intramuscular
11.1.1 Overview
11.1.2 Intramuscular: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Subcutaneous
11.2.1 Overview
11.2.2 Subcutaneous: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Others
11.3.1 Overview
11.3.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. South & Central America Veterinary Vaccines Market Revenue Analysis - by End User
12.1 Veterinary Hospitals
12.1.1 Overview
12.1.2 Veterinary Hospitals: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Veterinary Clinics
12.2.1 Overview
12.2.2 Veterinary Clinics: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. South & Central America Veterinary Vaccines Market - Country Analysis
13.1 South & Central America
13.1.1 South & Central America Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.1.1 South & Central America Veterinary Vaccines Market Revenue and Forecast and Analysis - by Country
13.1.2.2 Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.1.2.2.1 Brazil: South & Central America Veterinary Vaccines Market Share - by Technology
13.1.2.2.2 Brazil: South & Central America Veterinary Vaccines Market Share - by Animal Type
13.1.2.2.3 Brazil: South & Central America Veterinary Vaccines Market Share - by Companion
13.1.2.2.4 Brazil: South & Central America Veterinary Vaccines Market Share - by Livestock And Poultry
13.1.2.2.5 Brazil: South & Central America Veterinary Vaccines Market Share - by Route Of Administration
13.1.2.2.6 Brazil: South & Central America Veterinary Vaccines Market Share - by End User
13.2.3.3 Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2.3.3.1 Argentina: South & Central America Veterinary Vaccines Market Share - by Technology
13.2.3.3.2 Argentina: South & Central America Veterinary Vaccines Market Share - by Animal Type
13.2.3.3.3 Argentina: South & Central America Veterinary Vaccines Market Share - by Companion
13.2.3.3.4 Argentina: South & Central America Veterinary Vaccines Market Share - by Livestock And Poultry
13.2.3.3.5 Argentina: South & Central America Veterinary Vaccines Market Share - by Route Of Administration
13.2.3.3.6 Argentina: South & Central America Veterinary Vaccines Market Share - by End User
13.3.4.4 Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3.4.4.1 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Technology
13.3.4.4.2 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Animal Type
13.3.4.4.3 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Companion
13.3.4.4.4 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Livestock And Poultry
13.3.4.4.5 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by Route Of Administration
13.3.4.4.6 Rest of South & Central America: South & Central America Veterinary Vaccines Market Share - by End User
15 Industry Landscape
15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments
16 COMPANY PROFILES
16.1 Merck & Co Inc
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Boehringer Ingelheim International GmbH
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Ceva SanteAnimale
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Zoetis Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 Elanco Animal Health Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 Virbac SA
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Neogen Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Hester Biosciences Ltd
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 HIPRA SA
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Biovac LTD
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
17. Appendix
17.1 About The Insight Partners
List of Tables
Table 1. South & Central America Veterinary Vaccines Market Segmentation
Table 3. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 5. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 6. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 7. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 8. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 9. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 10. South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 11. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 12. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 13. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 14. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 15. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 18. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 19. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 20. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 21. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 22. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Technology
Table 24. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Animal Type
Table 25. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Companion
Table 26. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Livestock And Poultry
Table 27. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
List of Figures
Figure 1. South & Central America Veterinary Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Veterinary Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Veterinary Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Veterinary Vaccines Market Share (%) - by Technology, 2024 and 2031
Figure 8. Live Attenuated Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Recombinant Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Toxoid Vaccines: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. South & Central America Veterinary Vaccines Market Share (%) - by Animal Type, 2024 and 2031
Figure 14. Companion: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Livestock and Poultry: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. South & Central America Veterinary Vaccines Market Share (%) - by Companion, 2024 and 2031
Figure 17. Dogs: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Cat: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Horses: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South & Central America Veterinary Vaccines Market Share (%) - by Livestock And Poultry, 2024 and 2031
Figure 22. Chicken: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cattle: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. South & Central America Veterinary Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 26. Intramuscular: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Subcutaneous: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. South & Central America Veterinary Vaccines Market Share (%) - by End User, 2024 and 2031
Figure 30. Veterinary Hospitals: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Veterinary Clinics: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Others: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. South & Central America Veterinary Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 34. Brazil: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Argentina: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Rest of South & Central America: South & Central America Veterinary Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For